<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39311542</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1369-7625</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Health expectations : an international journal of public participation in health care and health policy</Title><ISOAbbreviation>Health Expect</ISOAbbreviation></Journal><ArticleTitle>Living With Spasticity During the COVID-19 Pandemic: A Qualitative Study of Patient, Carer and Physician Experiences.</ArticleTitle><Pagination><StartPage>e70032</StartPage><MedlinePgn>e70032</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70032</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/hex.70032</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Approximately 4.4 million people in England (8% of the total population) are living with a long-term neurological condition. Within this group of vulnerable individuals, there will be individuals living with severe spasticity that requires regular outpatient treatment with botulinum toxin injection. The closure of outpatient spasticity services during the pandemic impacted individuals who required spasticity treatment and their carers, as well as the specialist clinicians responsible for service delivery.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We aimed to gain insight into the experiences of individuals living with spasticity, their carers and a clinical spasticity service lead during the pandemic, and to reflect on potential learning for the future.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A qualitative study was designed using semi-structured interviews conducted by telephone. Participants comprised patients living with a long-term neurological condition who attended outpatient spasticity clinics before the start of the pandemic in England, primary carers who accompanied patients attending these clinics and a clinical spasticity service lead. Data were audio recorded, transcribed, anonymised and coded. Data analysis utilised the One Sheet of Paper thematic approach to identify themes, which were discussed and analysed by the interdisciplinary research team and two patient and carer participants.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of the 11 participants recruited, aged 36-77 years, seven comprised people living with spasticity related to a long-term neurological condition, three were carers and one was a clinical spasticity service lead. Six participants were male and five were female. Among the participants, four were stroke survivors, two were living with spinal cord injury and one was living with multiple sclerosis. Analysis revealed six major themes: experience of living with spasticity during the pandemic; impact of the pandemic on patient, carer and clinician health; access to and experience of outpatient clinic appointments; coping strategies during the pandemic; system improvements; and learning from the pandemic period.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These findings contribute research knowledge to a very limited research knowledge base and suggest that there is scope for improving system and service delivery through the allocation of research funding to senior clinicians working in this specialist area.</AbstractText><CopyrightInformation>© 2024 The Author(s). Health Expectations published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sakel</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6749-5229</Identifier><AffiliationInfo><Affiliation>East Kent Hospitals University NHS Foundation Trust, Canterbury, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Central England Rehabilitation Unit, South Warwickshire University NHS Foundation Trust, Leamington Spa Hospital, Warwickshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saunders</LastName><ForeName>Karen</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-0626-2477</Identifier><AffiliationInfo><Affiliation>Centre for Health Services Studies, School of Social Policy, Sociology and Social Research, Division for the Study of Law, Society and Social Justice, University of Kent, Canterbury, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faruqui</LastName><ForeName>Rafey</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2668-3316</Identifier><AffiliationInfo><Affiliation>Centre for Health Services Studies, School of Social Policy, Sociology and Social Research, Division for the Study of Law, Society and Social Justice, University of Kent, Canterbury, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Kent and Medway NHS and Social Care Partnership Trust, Maidstone, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keene</LastName><ForeName>Jamie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0003-0363-4703</Identifier><AffiliationInfo><Affiliation>King Edward VI Five Ways School, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilkinson</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9973-6477</Identifier><AffiliationInfo><Affiliation>School of Psychology, University of Kent, Canterbury, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>The authors received no specific funding for this work.</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Expect</MedlineTA><NlmUniqueID>9815926</NlmUniqueID><ISSNLinking>1369-6513</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009128" MajorTopicYN="Y">Muscle Spasticity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="Y">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007407" MajorTopicYN="N">Interviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID‐19 pandemic</Keyword><Keyword MajorTopicYN="N">botulinum toxin</Keyword><Keyword MajorTopicYN="N">lived experience</Keyword><Keyword MajorTopicYN="N">long‐term neurological condition</Keyword><Keyword MajorTopicYN="N">neuro‐rehabilitation</Keyword><Keyword MajorTopicYN="N">qualitative research</Keyword><Keyword MajorTopicYN="N">spasticity</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>8</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39311542</ArticleId><ArticleId IdType="pmc">PMC11418296</ArticleId><ArticleId IdType="doi">10.1111/hex.70032</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>“Timeline of UK Government Coronavirus Lockdowns and Measures
,” Institute for Government, March 2020 to December 2021, 2022, https://www.instituteforgovernment.org.uk/sites/default/files/2022-12/timeline-coronavirus-lockdown-december-2021.pdf.</Citation></Reference><Reference><Citation>Bavikatte G., Jacinto J., Deltombe T., and Wissel J., “Botulinum Toxin Services for Neurorehabiliation: Recommendations for Challenges and Opportunities During the COVID‐19 Pandemic,” Toxins 13 (2021): 584, 10.3390/toxins13080584.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins13080584</ArticleId><ArticleId IdType="pmc">PMC8402461</ArticleId><ArticleId IdType="pubmed">34437456</ArticleId></ArticleIdList></Reference><Reference><Citation>“The National Service Framework for Long
‐Term conditions,” Department of Health, 2005, https://assets.publishing.service.gov.uk/media/5a756bede5274a1baf95e73b/National_Service_Framework_for_Long_Term_Conditions.pdf.</Citation></Reference><Reference><Citation>“The Neurological Alliance
,” Neuro Numbers 2019, 2023, https://www.neural.org.uk/wp-content/uploads/2021/04/neuro-numbers-2019-1.pdf.</Citation></Reference><Reference><Citation>Özkan I., Polat Dunya C., and Demir S., “Life Experiences of Patients With Multiple Sclerosis about Their Spasticity: A Phenomenological Study,” Clinical Nursing Research 32, no. 1 (2023): 49–59, 10.1177/10547738221119346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10547738221119346</ArticleId><ArticleId IdType="pubmed">36154305</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes M. P., “An Overview of the Clinical Management of Spasticity,” in Upper Motor Neurone Syndrome and Spasticity. Clinical Management and Neurophysiology, eds. Barnes M. and Johnson G. (Cambridge: Cambridge University Press, 2009), 1–8, 10.1017/CBO9780511544866.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/CBO9780511544866.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Burridge J., Wood D., Hermens H., et al., “Theoretical and Methodological Considerations in the Measurement of Spasticity,” Disability and Rehabilitation 2005. 27(1–2):69–80, 10.1080/09638280400014592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638280400014592</ArticleId><ArticleId IdType="pubmed">15799144</ArticleId></ArticleIdList></Reference><Reference><Citation>Lance J. W., “Pathophysiology of Spasticity and Clinical Experience With Baclofen,” in Spasticity: Disordered Motor Control, eds. Lance J. W., Feldman R. G., Young R. R., and Koella W. P. (Chicago, Ill: Year Book, 1980), 185–204.</Citation></Reference><Reference><Citation>Dressler D., Bhidayasiri R., Bohlega S., et al., “Defining Spasticity: A New Approach Considering Current Movement Disorders Terminology and Botulinum Toxin Therapy,” Journal of Neurology 265, no. 4 (2018): 856–862, 10.1007/s00415-018-8759-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8759-1</ArticleId><ArticleId IdType="pubmed">29423615</ArticleId></ArticleIdList></Reference><Reference><Citation>Royal College of Physicians, British Society of Rehabilitation Medicine, The Chartered Society of Physiotherapy, Association of Chartered Physiotherapists in Neurology and the Royal College of Occupational Therapists. Spasticity in Adults: Management Using Botulinum Toxin (RCP: London, National Guidelines, 2018), 2E, http://www.rcplondon.ac.uk/guidelines-policy/spasticity-adults-management-using-botulinum-toxin.</Citation></Reference><Reference><Citation>Barnes M., Kocer S., Murie Fernandez M., Balcaitiene J., and Fheodoroff K., “An International Survey of Patients Living With Spasticity,” Disability and Rehabilitation 39, no. 14 (2017): 1428–1434, 10.1080/09638288.2016.1198432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638288.2016.1198432</ArticleId><ArticleId IdType="pubmed">27385274</ArticleId></ArticleIdList></Reference><Reference><Citation>
Ferreira E. F., Portugal D., Silva N., Peixoto C., Prates L., and Neves A. F., “Impact of Botulinum Toxin Consultation Shutdown Due to the Covid‐19 Pandemic on Spasticity Treatment: A Review of the Literature,” Advances in Clinical Toxicology
6, no. 2 (2021): 1–7, https://medwinpublishers.com/ACT/impact-of-botulinum-toxin-consultation-shutdown-due-to-the-covid--9-pandemic-on-spasticity-treatment-a-review-of-the-literature.pdf.</Citation></Reference><Reference><Citation>Dressler D. and Adib Saberi F., “Botulinum Toxin Therapy in the SARS‐COV‐2 Pandemic: Patient Perceptions From a German Cohort,” Journal of Neural Transmission 127 (2020): 1271–1274, 10.1007/s00702-020-02235-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-020-02235-6</ArticleId><ArticleId IdType="pmc">PMC7391233</ArticleId><ArticleId IdType="pubmed">32734554</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuschl Y., Bancher C., Brainin M., Dachenhausen A., Matz K., and Pinter M. M., “COVID‐19‐Related Delays of Botulinum Toxin Injections Have a Negative Impact on the Quality of Life of Patients With Dystonia and Spasticity: A Single‐Center Ambulatory Care Study,” Journal of Neural Transmission 129 (2022): 49–53, 10.1007/s00702-021-02430-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-021-02430-z</ArticleId><ArticleId IdType="pmc">PMC8541799</ArticleId><ArticleId IdType="pubmed">34689260</ArticleId></ArticleIdList></Reference><Reference><Citation>Edmonds W. A. and Kennedy T. D., An Applied Guide to Research Designs: Quantitative, Qualitative and Mixed Methods. 2E (London, UK: Sage, 2017).</Citation></Reference><Reference><Citation>Ladds E., Rushforth A., Wieringa S., et al., “Persistent Symptoms After Covid‐19: Qualitative Study of 114 ‘Long Covid’ Patients and Draft Quality Principles for Services,” BMC Health Services Research 20 (2020): 1144, 10.1186/s12913-020-06001-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkel I., Ljungqvist E., Arnby M., and Molander U., “Not Thinking That This Means the End When You Are Seriously Ill but Doing Something Positive about It'‐A Qualitative Study of Living With a Life‐Changing Disease,” Diseases 7, no. 3 (2019): 53, 10.3390/diseases7030053.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diseases7030053</ArticleId><ArticleId IdType="pmc">PMC6787749</ArticleId><ArticleId IdType="pubmed">31514413</ArticleId></ArticleIdList></Reference><Reference><Citation>Bury M., “Chronic Illness as Biographical Disruption,” Sociology of Health &amp; Illness 4, no. 2 (1982): 167–182.</Citation><ArticleIdList><ArticleId IdType="pubmed">10260456</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson D. L. and Ferguson P. M., “Qualitative Research in Special Education: Notes Toward an Open Inquiry Instead of a New Orthodoxy?,” Journal of the Association for Persons With Severe Handicaps 25, no. 3 (2000): 180–185, 10.2511/rpsd.25.3.180.</Citation><ArticleIdList><ArticleId IdType="doi">10.2511/rpsd.25.3.180</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor S. J., Bogdan R., and Devault M. L., Introduction to Qualitative Methods: A guidebook and resource, 4th ed. (New Jersey: Wiley, 2016).</Citation></Reference><Reference><Citation>Denzin N. and Lincoln Y., The Sage Handbook of Qualitative Research, 5th ed. (London: Sage, 2018).</Citation></Reference><Reference><Citation>Baricich A., Santamato A., Picelli A., et al., “Spasticity Treatment During Covid‐19 Pandemic: Clinical Recommendations,” Frontiers in Neurology 11 (2020): 719, 10.3389/fneur.2020.00719.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00719</ArticleId><ArticleId IdType="pmc">PMC7324716</ArticleId><ArticleId IdType="pubmed">32655491</ArticleId></ArticleIdList></Reference><Reference><Citation>“Long‐Term Neurological Conditions: Management at the Interface Between Neurology, Rehabilitation and Palliative Care,” Royal College of Physicians, Number 10, National Guidelines, 2008, https://www.rcplondon.ac.uk/guidelines-policy/long-term-neurological-conditions.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4953006</ArticleId><ArticleId IdType="pubmed">18478869</ArticleId></ArticleIdList></Reference><Reference><Citation>De Donno A., Acella A., Angrisani C., et al., “Suspension of Care for Patients with Spasticity During COVID‐19 Pandemic: Ethical and Medico‐Legal Point of View Starting From an Italian Study,” Frontiers in Medicine 8 (2021): 754456, 10.3389/fmed.2021.754456.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.754456</ArticleId><ArticleId IdType="pmc">PMC8669589</ArticleId><ArticleId IdType="pubmed">34917632</ArticleId></ArticleIdList></Reference><Reference><Citation>Erro R., Scannapieco S., Russo M., Picillo M., and Barone P., “Impact of Covid‐19 on Neurological Patients Attending a Botulinum Toxin Service,” Neurological Sciences 42 (2021): 433–435, 10.1007/s10072-020-04940-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04940-2</ArticleId><ArticleId IdType="pmc">PMC7690337</ArticleId><ArticleId IdType="pubmed">33242177</ArticleId></ArticleIdList></Reference><Reference><Citation>Santamato A., Facciorusso S., and Spina S., et al., “Discontinuation of Botulinum Neurotoxin Type‐A Treatment During COVID‐19 Pandemic: An Italian Survey in Post Stroke and Traumatic Brain Injury Patients Living With Spasticity,” European Journal of Physical and Rehabilitation Medicine 57, no. 3 (2021): 424–433, 10.23736/S1973-9087.20.06478-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S1973-9087.20.06478-3</ArticleId><ArticleId IdType="pubmed">33263248</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerstens H. C. J. W., Satink T., Nijkrake M. J., et al., “Stumbling, Struggling, and Shame Due to Spasticity: A Qualitative Study of Adult Persons With Hereditary Spastic Paraplegia,” Disability and Rehabilitation 42, no. 26 (2020): 3744–3751, 10.1080/09638288.2019.1610084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638288.2019.1610084</ArticleId><ArticleId IdType="pubmed">31079503</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerstens H. C. J. W., Satink T., Nijkrake M. J., et al., “Experienced Consequences of Spasticity and Effects of Botulinum Toxin Injections: A Qualitative Study Amongst Patients With Disabling Spasticity After Stroke,” Disability and Rehabilitation 43, no. 25 (2021): 3688–3695, 10.1080/09638288.2020.1746843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638288.2020.1746843</ArticleId><ArticleId IdType="pubmed">32255361</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacinto J., Lysandropoulos A., Leclerc M., and Calvi‐Gries F., “Experiences of Patients With Poststroke Spasticity Throughout a Botulinum Toxin Treatment Cycle: Results From a Prospective Ethnographic Study,” Frontiers in Neurology 13 (2022): 946500, 10.3389/fneur.2022.946500.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.946500</ArticleId><ArticleId IdType="pmc">PMC9479670</ArticleId><ArticleId IdType="pubmed">36119669</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhimani R. H., Mc Alpine C. P., and Henly S. J., “Understanding Spasticity From Patients' Perspectives Over Time,” Journal of Advanced Nursing 68, no. 11 (2012): 2504–2514, 10.1111/j.1365-2648.2012.05949.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2648.2012.05949.x</ArticleId><ArticleId IdType="pubmed">22339651</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J. A., “Semi‐Structured Interviewing,” in Rethinking Methods in Psychology, eds. Smith J. A., Harré R., and van Langenhove L. (London: Sage, 1995).</Citation></Reference><Reference><Citation>Farooq M. B. and And De Villiers C., “Telephonic Qualitative Research Interviews, When to Consider Them and How to Do Them,” Meditari Accountancy Research 25, no. 2 (2017): 291–316.</Citation></Reference><Reference><Citation>Drabble L., Trocki K. F., Salcedo B., Walker P. C., and Korcha R. A., “Conducting Qualitative Interviews by Telephone: Lessons Learned From a Study of Alcohol Use Among Sexual Minority and Heterosexual Women,” Qualitative Social Work 15, no. 1 (2016): 118–133, 10.1177/1473325015585613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1473325015585613</ArticleId><ArticleId IdType="pmc">PMC4722874</ArticleId><ArticleId IdType="pubmed">26811696</ArticleId></ArticleIdList></Reference><Reference><Citation>Cachia M. and Millward L., “The Telephone Medium and Semi‐Structured Interviews: a Complementary Fit,” Qualitative Research in Organizations and Management: An International Journal 6, no. 3 (2011): 265–277.</Citation></Reference><Reference><Citation>“Integrated Research Application System (IRAS)
,” accessed August 2024, https://www.myresearchproject.org.uk/.</Citation></Reference><Reference><Citation>“NHS Health Research Authority (HRA)
,” accessed August 2024, https://www.hra.nhs.uk/.</Citation></Reference><Reference><Citation>“UK Policy Framework for Health and Social Care Research
,” NHS Health Research Authority, accessed August 2024, https://www.hra.nhs.uk/planning-and-improving-research/policies-standards-legislation/uk-policy-framework-health-social-care-research/.</Citation></Reference><Reference><Citation>Ziebland S. and McPherson A., “Making Sense of Qualitative Data Analysis: An Introduction With Illustrations From Dipex (Personal Experiences of Health and Illness),” Medical Education 40 (2006): 405–414, 10.1111/j.1365-2929.2006.02467.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2929.2006.02467.x</ArticleId><ArticleId IdType="pubmed">16635119</ArticleId></ArticleIdList></Reference><Reference><Citation>Astbury N. M., Albury C., Nourse R., and Jebb S. A., “Participant Experiences of a Low‐Energy Total Diet Replacement Programme: A Descriptive Qualitative Study,” PLoS ONE 15, no. 9 (2020): e0238645, 10.1371/journal.pone.0238645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0238645</ArticleId><ArticleId IdType="pmc">PMC7478843</ArticleId><ArticleId IdType="pubmed">32898176</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbot A., Salinas M., Albury C., and Ziebland S., “People With Weight‐Related Long‐Term Conditions Want Support From GPs: A Qualitative Interview Study,” Clinical Obesity 11 (2021): e12471, 10.1111/cob.12471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cob.12471</ArticleId><ArticleId IdType="pubmed">34085406</ArticleId></ArticleIdList></Reference><Reference><Citation>Artola M., Hernando A., Vidal O., et al., “The Role of Specialist Nurses in Detecting Spasticity and Related Symptoms in Multiple Sclerosis,” Journal of Clinical Nursing 32 (2023): 3496–3503, 10.1111/jocn.16421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.16421</ArticleId><ArticleId IdType="pubmed">35799407</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacinto J., Lysandropoulos A., Leclerc M., and Calvi‐Gries F., “Experiences of Patients With Poststroke Spasticity Throughout a Botulinum Toxin Treatment Cycle: Results From a Prospective Ethnographic Study,” Frontiers in Neurology 13 (2022): 946500, 10.3389/fneur.2022.946500.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.946500</ArticleId><ArticleId IdType="pmc">PMC9479670</ArticleId><ArticleId IdType="pubmed">36119669</ArticleId></ArticleIdList></Reference><Reference><Citation>Doussoulin A., Bacco J. L., Rivas C., and Saiz J. L., “Association Between Postural Patterns of Spastic Upper Extremity and Functional Independence after TBi and Stroke,” NeuroRehabilitation 46 (2020): 551–559.</Citation><ArticleIdList><ArticleId IdType="pubmed">32508335</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders K., Sakel M., and Cooper C. L., “Is It Time for a Paradigmatic Shift in Relation to Healthcare in the Uk? A Reflection,” BMJ Leader 7 (2023): 251–254, 10.1136/leader-2023-000762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/leader-2023-000762</ArticleId><ArticleId IdType="pubmed">37208156</ArticleId></ArticleIdList></Reference><Reference><Citation>Hacker K. A., Briss P. A., Richardson L., Wright J., and Petersen R., “COVID‐19 and Chronic Disease: The Impact Now and in the Future,” Preventing Chronic Disease 18 (2021): 210086, 10.5888/pcd18.210086.</Citation><ArticleIdList><ArticleId IdType="doi">10.5888/pcd18.210086</ArticleId><ArticleId IdType="pmc">PMC8220960</ArticleId><ArticleId IdType="pubmed">34138696</ArticleId></ArticleIdList></Reference><Reference><Citation>
Maccaro A., Audia C., Stokes K., et al., “Pandemic Preparedness: A Scoping Review of Best and Worst Practices From COVID‐19,” Healthcare
11 (2023): 2572, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530798/.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10530798</ArticleId><ArticleId IdType="pubmed">37761769</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>